Genetic Researchers Find New, Low-Cost Approach For Ovarian And Breast Cancer Testing
9/29/2012
In a new genetic study, researchers said they may have found a way to cut the cost of genetic screening for breast and ovarian cancers from $3000 to $400. Three teams of infertility scientists in New York and Austria collaborated to study gene mutations that increase a woman's likelihood of breast and ovarian cancers...
Following Radiation In Prostate Cancer, Risk Markers Discovered For Erectile Dysfunction
9/29/2012
In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation...
Genetic Researchers Find New, Low-Cost Approach For Ovarian And Breast Cancer Testing
9/29/2012
In a new genetic study, researchers said they may have found a way to cut the cost of genetic screening for breast and ovarian cancers from $3000 to $400. Three teams of infertility scientists in New York and Austria collaborated to study gene mutations that increase a woman's likelihood of breast and ovarian cancers...
Prostate Cancer That Spreads To Bones Benefits From Targeted Therapy
9/28/2012
Prostate tumors that have spread to people's bones can be reduced in size, by a newly found cancer drug, which also helps alleviate bone pain, according to a new study. A novel cancer therapy callled Cabozantinib, which targets tumors specifically, was found to have clear and impressive results...
Blood Test Developed That Accurately Detects Early Stages Of Lung, Breast Cancer In Humans
9/28/2012
Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer. In less than an hour, the test can detect breast cancer and non-small cell lung cancer -- the most common type of lung cancer -- before symptoms like coughing and weight loss start...
Unexpected Epigenetic Function Of Common Cancer-Causing Protein
9/28/2012
Squamous cell carcinoma (SCC) is diagnosed in about 700,000 people in the United States every year. Commonly contributing to SCC is a protein called DNp63a - it goes abnormally high and the ability of a patient's body to kill cancer cells goes abnormally low. In many cases of SCC, it's just that simple...
Colorectal Cancer Gene Database Helpful In Furthering Research
9/28/2012
The CRCgene database, which gathers all genetic association studies on colorectal cancer, allows for researchers to accurately interpret the risk factors of the disease and provides insight into the direction of further colorectal cancer research, according to a study published September 27 in the Journal of the National Cancer Institute...
Computer Models Helping To Reduce Acrylamide Levels In French Fries
9/28/2012
The process for preparing frozen, par-fried potato strips - distributed to some food outlets for making french fries - can influence the formation of acrylamide in the fries that people eat, a new study has found...
Blood Test Developed That Accurately Detects Early Stages Of Lung, Breast Cancer In Humans
9/28/2012
Researchers at Kansas State University have developed a simple blood test that can accurately detect the beginning stages of cancer. In less than an hour, the test can detect breast cancer and non-small cell lung cancer -- the most common type of lung cancer -- before symptoms like coughing and weight loss start...
Unexpected Epigenetic Function Of Common Cancer-Causing Protein
9/28/2012
Squamous cell carcinoma (SCC) is diagnosed in about 700,000 people in the United States every year. Commonly contributing to SCC is a protein called DNp63a - it goes abnormally high and the ability of a patient's body to kill cancer cells goes abnormally low. In many cases of SCC, it's just that simple...